Citadel Advisors’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.5K | Buy |
210,128
+160,555
| +324% | +$48.5K | ﹤0.01% | 5407 |
|
|
2025
Q1 | $14.1K | Buy |
+49,573
| New | +$14.1K | ﹤0.01% | 5657 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5960 |
|
|
2024
Q3 | – | Sell |
-53,349
| Closed | -$141K | – | 5788 |
|
|
2024
Q2 | $141K | Sell |
53,349
-54,765
| -51% | -$145K | ﹤0.01% | 4802 |
|
|
2024
Q1 | $296K | Sell |
108,114
-1,974
| -2% | -$5.41K | ﹤0.01% | 4408 |
|
|
2023
Q4 | $268K | Sell |
110,088
-3,407
| -3% | -$8.28K | ﹤0.01% | 4335 |
|
|
2023
Q3 | $229K | Sell |
113,495
-101,491
| -47% | -$205K | ﹤0.01% | 4450 |
|
|
2023
Q2 | $634K | Sell |
214,986
-289,372
| -57% | -$854K | ﹤0.01% | 3413 |
|
|
2023
Q1 | $1.26M | Sell |
504,358
-79,511
| -14% | -$199K | ﹤0.01% | 2961 |
|
|
2022
Q4 | $1.85M | Buy |
583,869
+143,088
| +32% | +$454K | ﹤0.01% | 2639 |
|
|
2022
Q3 | $1.31M | Sell |
440,781
-408,206
| -48% | -$1.21M | ﹤0.01% | 3145 |
|
|
2022
Q2 | $2.59M | Buy |
848,987
+148,100
| +21% | +$452K | ﹤0.01% | 2489 |
|
|
2022
Q1 | $9.46M | Sell |
700,887
-62,150
| -8% | -$839K | ﹤0.01% | 1451 |
|
|
2021
Q4 | $9.94M | Sell |
763,037
-372,512
| -33% | -$4.85M | ﹤0.01% | 1466 |
|
|
2021
Q3 | $10.7M | Sell |
1,135,549
-61,157
| -5% | -$574K | ﹤0.01% | 1383 |
|
|
2021
Q2 | $12.3M | Sell |
1,196,706
-66,364
| -5% | -$680K | ﹤0.01% | 1286 |
|
|
2021
Q1 | $23.2M | Buy |
1,263,070
+101,912
| +9% | +$1.88M | 0.01% | 841 |
|
|
2020
Q4 | $39.8M | Buy |
1,161,158
+83,143
| +8% | +$2.85M | 0.01% | 530 |
|
|
2020
Q3 | $19.9M | Buy |
+1,078,015
| New | +$19.9M | 0.01% | 746 |
|